Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery

NYU Langone Health

Overview

The purpose of this study is to determine the efficacy of sphenopalatine ganglion (SPG) block to prevent shoulder tip pain following primary laparoscopic gastric banding, band revision, band replacement, primary sleeve gastrectomy or revision of sleeve gastrectomy. Shoulder tip pain (STP) is a common problem after laparoscopic surgery, manifesting in the post-anesthesia care unit and for days or possibly weeks thereafter (Dixon 2005). Systemic analgesics including opioids and non-steroidal anti-inflammatory drugs (NSAIDs) do not reliably relieve STP. This study is designed to determine if the SPG block, a simple and low-risk procedure, effectively treats STP after laparoscopic bariatric surgery.

This is a randomized, placebo-controlled, parallel group prospective, double-blind study. The primary outcome variable will be change in STP from \> 4 before to after treatment in the PACU after primary laparoscopic gastric banding, band revision, band replacement, sleeve gastrectomy, or revision of sleeve gastrectomy. Investigators hope to achieve a decline in STP in 2 units after treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Obesity

Interventions

4% LidocaineDRUG

SalineOTHER

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Elective primary laparoscopic gastric banding surgery. * Laparoscopic band revision surgery * Laparoscopic band replacement surgery. * Sleeve gastrectomy. * Revision of sleeve gastrectomy. * American Society of Anesthesiologists Class 2 or 3. * No allergy to study drugs. * Facility with English language to allow compliance with study protocol. Exclusion Criteria: * American Society of Anesthesiologists Class 4 or 5. * Allergy to lidocaine or to any local anesthetic * Allergy to oxymetazoline (Afrin) * Pregnancy * Bleeding diathesis * Known nasal pathology including active sinusitis * Previous nasal surgery * Preoperative anticoagulant use OTHER THAN aspirin 81 mg and/or heparin 5000 U SQ bid administered for DVT prophylaxis. * Acute psychiatric disease * History of chronic right or left shoulder pain * Current opioid use * Any patient that the study team feels will be unable to comply with all protocol related procedures * Concurrent participation in another clinical trial

Locations (1)

New York University School of Medicine

New York, New York, United States

Outcomes

Primary Outcomes

Change in STP as assessed by Numeric Rating Scale (NRS-11), from before to after the treatment in the PACU after receiving a 30-minute unilateral SPG block or bilateral SPG block

subject will be asked to rate her/his pain from zero to ten with zero being "no pain" to ten being "the worst pain imaginable."

Time frame: Baseline, 30 Minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.